University of Crete (UOC)
Assessment of metal nanoparticles' uptake and biocompatibility with endothelial cells in vitro: effects on viability, activation, basement membrane and glycocalyx constitution
Abstract
dc:descriptionThe vascular endothelium is the primary biological barrier to intravenously administered nanotherapeutics, governing their systemic circulation, safety, and targeting efficiency. This doctoral thesis provides a comprehensive evaluation of nanoparticle-endothelial interactions, focusing on two distinct paradigms: surface-engineered stealth delivery and biomimetic receptor-mediated transport. In the first part of the study, iron oxide nanoparticles (IONPs) were functionalized with hydroxyethyl starch (HES) to evaluate their biocompatibility with human microvascular endothelial cells (HMEC-1). Physicochemical characterization confirmed that HES coating provides superior stability and a "stealth" biological identity. Our results demonstrated that IONPs@HES exhibit exceptional biocompatibility, maintaining endothelial viability and proliferation even under acute inflammatory stress. Mechanistic analysis revealed that these nanoparticles remain "immunologically silent," as they do not induce expression of inflammatory markers such as ICAM-1. At the intracellular level, IONPs@HES demonstrated homeostatic neutrality, being efficiently internalized without perturbing autophagic flux or triggering ferroptotic signaling. The phosphorylation of Caveolin-1 (p-CAV1) was identified as a key adaptive response governing safe membrane reorganization during nanoparticle uptake. The second part of the thesis investigated a biomimetic approach for crossing the blood-brain barrier (BBB). Curcumin, a potent but poorly soluble therapeutic, was encapsulated within H-ferritin (HFn) nanocages. The HFn-CUR nanoformulation significantly improved the solubility and stability of curcumin. Utilizing an in vitro BBB model, we demonstrated that HFn-CUR achieves superior trans-endothelial transport compared to free curcumin by exploiting the endogenous TfR1 receptormediated transcytosis pathway. This translocation occurred without compromising the integrity of the endothelial tight junctions. In conclusion, this research delineates that the fate of engineered nanocarriers at the vascular interface is dictated by their synthetic identity and biological corona. By balancing surface engineering to promote endothelial quiescence with biomimetic design to enhance transport, this work provides a robust framework for developing sophisticated nanomedicines tailored to complex vascular and neurological disorders.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Thrapsanioti, Lydia-Nefeli
- Θραψανιώτη, Λυδία-Νεφέλη
Subjects
dc:subject × 22- Νανοσωματίδια οξειδίου του σιδήρου
- Ενδοθηλιακά κύτταρα
- Υδροξυαιθυλοάμυλο
- Νανοκάψουλες φερριτίνης
- Αιματοεγκεφαλικός φραγμός
- Αυτοφαγία
- Βιοσυμβατότητα
- Iron oxide nanoparticles
- Endothelial cells
- Hydroxyethyl starch
- Ferritin nanocages
- Blood–brain barrier
- Autophagy
- Biocompatibility
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μοριακή ιατρική
- Τοξικολογία
- Basic Medicine
- Medical and Health Sciences
- Molecular Medicine
- Toxicology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62121